alpha amylase
Botanicalexperimental
α-Amylase is an enzyme that hydrolyses α bonds of large, α-linked polysaccharides, such as starch and glycogen, yielding shorter chains thereof, dextrins, and maltose, through the following biochemical process:Endohydrolysis of (1→4)-α-D-glucosidic linkages in polysaccharides containing three or more (1→4)-α-linked D-glucose units — Wikipedia
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02192892)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaΑ-Amylase ↗
- WikipediaAlpha-amylase ↗
Also known as
- alpha amylase
- alpha-amylase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05614726 | N/A | Jun 18, 2021 | Biohm Health, LLC, The Center for Applied Health Sciences, LLC |
| NCT02192892 | N/A | Jun 1, 2014 | DSM, United Nations |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biohm Health, LLC | For profit | 1 | 0 | 1 | 2021 |
| DSM | For profit | 1 | 1 | 1 | 2014 |
| The Center for Applied Health Sciences, LLC | Academic/Hospital | 1 | 1 | 1 | 2021 |
| United Nations | Government | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1